Recommended Topic Related To:

Teslascan

"The U.S. Food and Drug Administration today notified Ranbaxy Laboratories, Ltd., that it is prohibited from manufacturing and distributing active pharmaceutical ingredients (APIs) from its facility in Toansa, India, for FDA-regulated drug product"...

Teslascan

TESLASCAN 0.01 mmol/ml Solution for infusion (mangafodipir)
SPC approved in Renewal in the Centralized procedure in EU

DRUG DESCRIPTION

Name Of The Medicinal Product

TESLASCAN 0.01 mmol/ml solution for infusion (mangafodipir) .

Qualitative And Quantitative Composition

Each ml contains 7.57 mg of anhydrous mangafodipir trisodium, 0.01 mmol (10 μmol), equivalent to 6.91 mg of mangafodipir. 50 ml contains 378.5 mg of anhydrous mangafodipir trisodium, 0.50 mmol (500 μmol), equivalent to 345.5 mg of mangafodipir.

Excipient: Sodium 0.16 mmol (3.6 mg)/ml equivalent to 126 mg per normal dose of 35 ml.

For a full list of excipients, see the HOW SUPPLIED section.

Pharmaceutical Form

Solution for infusion

A clear bright to dark yellow solution,

TESLASCAN (mangafodipir) has the following physicochemical properties:

pH 7.0-8.0.
Osmolality (mosmol/kg H2O) at 37 °C 290
Viscosity (mPa.s) at 20 °C 1.0
Viscosity (mPa.s) at 37 °C 0.7
Density (g/ml) at 20 °C 1.01

Last reviewed on RxList: 3/3/2009
This monograph has been modified to include the generic and brand name in many instances.

A A A

Report Problems to the Food and Drug Administration

 

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


Women's Health

Find out what women really need.